SEARCH

SEARCH BY CITATION

References

  • Andreasen N. C., O'Leary D. S., Flaum M., Nopoulos P., Watkins G. L., Boles Ponto L. L. and Hichwa R. D. (1997) Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349, 17301734.
  • Brenman J. E., Christopherson K. S., Craven S. E., McGee A. W. and Bredt D. S. (1996) Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J. Neurosci. 16, 74077415.
  • Bressan R. A. and Pilowsky L. S. (2000) Imaging the glutamatergic system in vivo– relevance to schizophrenia. Eur. J. Nucl. Med. 27, 17231731.
  • Castren E., Da Penha Berzaghi M., Lindholm D. and Thoenen H. (1993) Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain. Exp. Neurol. 122, 244252.
  • Chen L., Chetkovich D. M., Petralia R. S., Sweeney N. T., Kawasaki Y., Wenthold R. J., Bredt D. S. and Nicoll R. A. (2000) Stargazing regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 408, 936943.
  • Cho K. O., Hunt C. A. and Kennedy M. B. (1992) The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 9, 929942.
  • Chung H. J., Xia J., Scannevin R. H., Zhang X. and Huganir R. L. (2000) Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J. Neurosci. 20, 72587267.
  • Cull-Candy S., Brickley S. and Farrant M. (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327335.
  • Daw M. I., Chittajallu R., Bortolotto Z. A., Dev K. K., Duprat F., Henley J. M., Collingridge G. L. and Isaac J. T. (2000) PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron 28, 873886.
  • Dev K. K., Nishimune A., Henley J. M. and Nakanishi S. (1999) The protein kinase Calpha binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits. Neuropharmacology 38, 635644.
  • Dong H., O'Brien R. J., Fung E. T., Lanahan A. A., Worley P. F. and Huganir R. L. (1997) GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386, 279284.
  • Dong H., Zhang P., Song I., Petralia R. S., Liao D. and Huganir R. L. (1999) Characterization of the glutamate receptor-interacting proteins GRIP1 and GRIP2. J. Neurosci. 19, 69306941.
  • Duncan G. E., Zorn S. and Lieberman J. A. (1999) Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia. Mol. Psychiatry 4, 418428.
  • Eastwood S. L., Burnet P. W. and Harrison P. J. (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66, 309319.
  • Eastwood S. L., Burnet P. W. and Harrison P. J. (1997) GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase polymerase chain reaction (RT-PCR) study. Mol. Brain Res. 44, 9298.
  • El-Husseini A. E., Schnell E., Chetkovich D. M., Nicoll R. A. and Bredt D. S. (2000) PSD-95 involvement in maturation of excitatory synapses. Science 290, 13641368.
  • Fanning A. S. and Anderson J. M. (1999) Protein modules as organizers of membrane structure. Curr. Opin. Cell Biol. 22, 183190.
  • Harrison P. J. (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593624.
  • Harrison P. J., McLaughlin D. and Kerwin R. W. (1991) Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337, 450452.
  • Hayashi Y., Shi S. H., Esteban J. A., Piccini A., Poncer J. C. and Malinow R. (2000) Driving AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1 and PDZ domain interaction. Science 287, 22622267.
  • Honer W. G., Falkai P., Chen C., Arango V., Mann J. J. and Dwork A. J. (1999) Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91, 12471255.
  • Imai C., Sugai T., Iritani S., Niizato K., Nakamura R., Makifuchi T., Kakita A., Takahashi H. and Nawa H. (2001) A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients. Neurosci. Lett. 305, 185188.
  • Iwakura Y., Nagano T., Kawamura M., Horikawa H., Ibaraki K., Takei N. and Nawa H. (2001) N-Methyl-d-aspartate-induced alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptor down–regulation involves interaction of the C-terminal terminus of GluR2/3 with Pick1. Ligand-binding studies using Sindbis vectors carrying AMPA receptor decoys. J. Biol. Chem. 276, 4002540032.
  • Jourdi H., Xiong H., Takei N., Narisawa-Saito M. and Nawa H. (2001) BDNF enhanced AMPA-receptor expression and stability via their interaction with partner postsynaptic density proteins. Soc. Neurosci. Abstr. 27, 32.5.
  • Karson C. N., Mrak R. E., Schluterman K. O., Sturner W. Q., Sheng J. G. and Griffin W. S. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’. Mol. Psychiatry 4, 3945.
  • Kerwin R. W. and Harrison P. J. (1997) Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non N-methyl-d-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol. Psychiatry 41, 636643.
  • Kim E., Cho K. O., Rothschild A. and Sheng M. (1996) Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins. Neuron 17, 103113.
  • Kornau H. C., Schenker L. T., Kennedy M. B. and Seeburg P. H. (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269, 17371740.
  • Lahti A. C., Holcomb H. H., Medoff D. R. and Tamminga C. A. (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6, 869872.
  • Leonard A. S., Davare M. A., Horne M. C., Garner C. C. and Hell J. W. (1998) SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit. J. Biol. Chem. 273, 1951819524.
  • Linden A. M., Vasanen J., Storvik M., Lakso M., Korpi E. R., Wong G. and Castren E. (2001) Uncompetitive antagonists of the N-methyl-d-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex. Pharmacol. Toxicol. 88, 98105.
  • Meador-Woodruff J. H., King R. E., Damask S. P. and Bovenkerk K. A. (1996) Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine. Mol. Psychiatry 1, 4153.
  • Migaud M., Charlesworth P., Dempster M., Webster L. C., Watabe A. M., Makhinson M., He Y., Ramsay M. F., Morris R. G., Morrison J. H., O'Dell T. J. and Grant S. G. (1998) Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396, 433439.
  • Mohn A. R., Gainetdinov R. R., Caron M. G. and Koller B. H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427436.
  • Muller B. M., Kistner U., Veh R. W., Cases-Langhoff C., Becker B., Gundelfinger E. D. and Garner C. C. (1995) Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J. Neurosci. 15, 23542366.
  • Muller B. M., Kistner U., Kindler S., Chung W. J., Kuhlendahl S., Fenster S. D., Lau L. F., Veh R. W., Huganir R. L., Gundelfinger E. D. and Garner C. C. (1996) SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17, 255265.
  • Nagano T., Jourdi H. and Nawa H. (1998) Emerging roles of Dlg-like PDZ proteins in the organization of the NMDA-type glutamatergic synapse. J. Biochem. (Tokyo) 124, 869875.
  • O'Brien R. J., Lau L. F. and Huganir R. L. (1998) Molecular mechanisms of glutamate receptor clustering at excitatory synapses. Curr. Opin. Neurobiol. 8, 364369.
  • Osten P., Khatri L., Perez J. L., Kohr G., Giese G., Daly C., Schulz T. W., Wensky A., Lee L. M. and Ziff E. B. (2000) Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron 27, 313325.
  • Sans N., Racca C., Petralia R. S., Wang Y. X., McCallum J. and Wenthold R. J. (2001) Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway. J. Neurosci. 21, 75067516.
  • Sato M., Suzuki K. and Nakanishi S. (2001) NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells. J. Neurosci. 21, 37973805.
  • Scannevin R. H. and Huganir R. L. (2000) Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. Neurosci. 1, 133141.
  • Selemon L. D., Rajkowska G. and Goldman-Rakic P. S. (1995) Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 52, 805818.
  • Sokolov B. P. (1998) Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of ‘neuroleptic-free’ schizophrenics: Evidence on reversible up-regulation by typical neuroleptics. J. Neurochem. 71, 24542464.
  • Sprengel R., Suchanek B., Amico C., Brusa R., Burnashev N., Rozov A., Hvalby O., Jensen V., Paulsen O., Andersen P., Kim J. J., Thompson R. F., Sun W., Webster L. C., Grant S. G., Eilers J., Konnerth A., Li J., McNamara J. O. and Seeburg P. H. (1998) Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92, 279289.
  • Srivastava S., Osten P., Vilim F. S., Khatri L., Inman G., States B., Daly C., DeSouza S., Abagyan R., Valtschanoff J. G., Weinberg R. J. and Ziff E. B. (1998) Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP. Neuron 21, 581591.
  • Suzuki T., Ito J., Takagi H., Saitoh F., Nawa H. and Shimizu H. (2001) Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Mol. Brain Res. 89, 2028.
  • Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T. and Nawa H. (2000) Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5, 293300.
  • Wakabayashi K., Narisawa-Saito M., Iwakura Y., Arai T., Ikeda K., Takahashi H. and Nawa H. (1999) Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease. Neurobiol. Aging 20, 287295.
  • Weickert C. S. and Kleinman J. E. (1998) The neuroanatomy and neurochemistry of schizophrenia. Psychiatr. Clin. North Am. 21, 5775.
  • Weinberger D. R., Berman K. F. and Zec R. F. (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 43, 114124.
  • Xia J., Zhang X., Staudinger J. and Huganir R. L. (1999) Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron 22, 179187.